Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Toshiyuki Morisawa"'
Autor:
Takaaki Eguchi, Osamu Inatomi, Shuhei Shintani, Kenji Momose, Tomoya Sako, Megumi Takagi, Daiki Fumihara, Kazuki Inoue, Norio Katayama, Toshiyuki Morisawa, Takumi Ota, Yoshihisa Tsuji
Publikováno v:
JGH Open, Vol 8, Iss 8, Pp n/a-n/a (2024)
Abstract Background and Aim Elobixibat is a triple mode of action laxative that increases water secretion into the colon, promotes colonic motility, and reestablishes the defecation desire. This study aims to evaluate the effectivity and safety of el
Externí odkaz:
https://doaj.org/article/f300de57ffdd42b585430ee2f91dd752
Autor:
Takuma Imakita, Hirotaka Matsumoto, Katsuya Hirano, Toshiyuki Morisawa, Azusa Sakurai, Yuki Kataoka
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-5 (2019)
Abstract Background Osimertinib, the third-generation epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI), has become the standard treatment in cases where rebiopsy reveals T790M mutation after the first-line EGFR-TKI treatment. How
Externí odkaz:
https://doaj.org/article/ac04226c8a6d4cff938b254d21cd02ac
Publikováno v:
Endoscopy International Open, Vol 08, Iss 05, Pp E623-E627 (2020)
Background and aims Although various solutions have been tested for submucosal injections during endoscopic treatment, the ideal solution has not been established. We investigated the suitability of a cellulose nanofiber (CNF) dispersion with high vi
Externí odkaz:
https://doaj.org/article/ceb97044d9cf43e7b05904bb3a45ca18
Autor:
Toshiyuki Morisawa, Takaaki Eguchi, Masanori Matsumoto, Hiroki Hashimura, Seitaro Ikeoka, Takahiro Miura, Megumi Takagi, Tetsuya Yoshizaki, Norihiro Okamoto, Kenji Momose, Tatsuya Matsuda, Takafumi Otsuka, Akihiko Okada
Publikováno v:
Digestive Diseases. 39:10-15
Introduction: Lubiprostone is an effective treatment of chronic constipation (CC). However, as with other stimulant or osmotic laxatives, adverse events (AEs) can make it difficult to continue treatment. This article investigates AE risk factors asso
Autor:
Katsuya Hirano, Toshiyuki Morisawa, Takuma Imakita, Yuki Kataoka, Hirotaka Matsumoto, Azusa Sakurai
Publikováno v:
Kompass Pneumologie. 7:306-310
Hintergrund: Osimertinib, ein epidermaler Wachstumsfaktorrezeptor-Tyrosinkinasehemmer (Epidermal Growth Factor Receptor-Tyrosine-kinase Inhibitor, EGFR-TKI) der 3. Generation, ist mittlerweile die Standardtherapie in Fällen, in denen die Rebiopsie n
Publikováno v:
Clinical Gastroenterology and Hepatology. 20:e348
Autor:
Shohei Amioka, Tetsuya Yoshizaki, Tsubasa Yamaguchi, Toshiyuki Morisawa, Akihiko Okada, Takaaki Eguchi, Masanori Matsumoto, Tomoya Sako, Tatsuya Matsuda, Kenji Momose, Kazuki Inoue, Norio Katayama, Takahiro Nonaka, Seitaro Ikeoka, Maho Fujinami, Megumi Takagi, Mari Noda
Publikováno v:
Digestive diseases (Basel, Switzerland). 39(4)
Introduction: Elobixibat is a new laxative, but its efficacy and adverse events (AEs) are insufficiently examined compared with those of other laxatives. Hence, by propensity score (PS) matching, we compared the effects and AEs between elobixibat and
Autor:
Tetsuya, Yoshizaki, Toshiyuki, Morisawa, Maho, Fujinami, Tatsuya, Matsuda, Norio, Katayama, Kazuki, Inoue, Masanori, Matsumoto, Seitaro, Ikeoka, Megumi, Takagi, Tomoya, Sako, Kenji, Momose, Mari, Noda, Takaaki, Eguchi, Akihiko, Okada
Publikováno v:
Alimentary pharmacologytherapeuticsREFERENCES. 53(1)
Vonoprazan, a potassium-competitive acid blocker, is used for acid-related diseases. Occasionally, small white protrusions called "stardust" gastric mucosa have been detected in the stomachs of some patients taking vonoprazan.To determine the inciden
Autor:
Seitaro Ikeoka, Tetsuya Yoshizaki, Tatsuya Matsuda, Masanori Matsumoto, Toshiyuki Morisawa, Megumi Takagi, Takaaki Eguchi, Akihiko Okada, Kenji Momose, Norio Katayama
Publikováno v:
Clinical journal of gastroenterology. 13(6)
Pyogenic granulomas (PG) are lobular capillary hemangiomas mostly found in the mucous membranes of the skin and oral cavity, and rarely occur in the gastrointestinal tract. Here we describe a case of an 84-year-old patient with alcoholic cirrhosis wh
Publikováno v:
Endoscopy International Open, Vol 08, Iss 05, Pp E623-E627 (2020)
Endoscopy International Open
Endoscopy International Open
Background and aims Although various solutions have been tested for submucosal injections during endoscopic treatment, the ideal solution has not been established. We investigated the suitability of a cellulose nanofiber (CNF) dispersion with high vi